To achieve this, we upregulated the LYPD1 levels in T24 and 5637 cells (Fig. 10B), and then employed wound healing and transwell assays to assess changes in the invasion and migration abilities of BLCA cells. The gene discussed is LYPD1; the disease is bladder transitional cell carcinoma.